Page last updated: 2024-11-02

oxyphenbutazone and Bone Marrow Diseases

oxyphenbutazone has been researched along with Bone Marrow Diseases in 7 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Bone Marrow Diseases: Diseases involving the BONE MARROW.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BELFRAGE, S1
Andersson, DE1
Langworth, S1
Newman, HC1
Ost, A1
Zeile, G1
Wandel, E1
Bork, K1
Krönig, B1
Smith, CS1
Chinn, S1
Watts, RW1
Hausmann, K2
Skrandies, G2
Sachtleben, P2
Cohrs, U1
Hauswaldt, C1
Hunstein, W1

Other Studies

7 other studies available for oxyphenbutazone and Bone Marrow Diseases

ArticleYear
[SERIOUS ILLNESS ASSOCIATED WITH TANDERIL TREATMENT].
    Svenska lakartidningen, 1964, May-13, Volume: 61

    Topics: Anemia; Anemia, Aplastic; Bone Marrow Diseases; Exanthema; Fever; Geriatrics; Nephrosis; Oxyphenbuta

1964
Reversible bone marrow granulomas-adverse effect of oxyphenbutazone therapy.
    Acta medica Scandinavica, 1980, Volume: 207, Issue:1-2

    Topics: Bone Marrow; Bone Marrow Diseases; Female; Granuloma; Humans; Middle Aged; Oxyphenbutazone

1980
[Lyell's syndrome with transient bone marrow depression caused by oxyphenebutazone].
    MMW, Munchener medizinische Wochenschrift, 1979, Jul-13, Volume: 121, Issue:28

    Topics: Adult; Anemia; Blood Cell Count; Bone Marrow Cells; Bone Marrow Diseases; Humans; Male; Oxyphenbutaz

1979
The sensitivity of human bone marrow granulocyte/monocyte precursor cells to phenylbutazone, oxyphenbutazone and gamma-hydroxyphenylbutazone in vitro, with observations on the bone marrow colony formation in phenylbutazone-induced granulocytopoenia.
    Biochemical pharmacology, 1977, May-01, Volume: 26, Issue:9

    Topics: Adult; Aged; Agranulocytosis; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Depression, Chem

1977
[Current aspects of iatrogenic lesions of the bone marrow].
    Minerva medica, 1976, Nov-14, Volume: 67, Issue:55

    Topics: Anemia, Aplastic; Anemia, Macrocytic; Anemia, Megaloblastic; Bone Marrow Diseases; Chloramphenicol;

1976
[Present aspects of bone marrow lesions due to drugs (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1974, Sep-20, Volume: 116, Issue:38

    Topics: Anemia, Aplastic; Bone Marrow Diseases; Chloramphenicol; Drug-Related Side Effects and Adverse React

1974
[The modification of experimental bone marrow fibrosis after repeated administration of foreign proteins by antiphlogistics and prednisolone acetate].
    Blut, 1969, Volume: 19, Issue:7

    Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Blood Cell Count; Blood Platelets; Body Weight; Bone

1969